-
Je něco špatně v tomto záznamu ?
Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients
A. Folta, T. Jurcek, B. Kubesova, D. Zackova, L. Semerad, J. Mayer, I. Jeziskova
Jazyk angličtina Země Spojené státy americké
Typ dokumentu dopisy, práce podpořená grantem
- MeSH
- bcr-abl fúzní proteiny genetika MeSH
- chronická myeloidní leukemie * diagnóza genetika MeSH
- lidé MeSH
- myeloidní leukemie * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018714
- 003
- CZ-PrNML
- 005
- 20210830100311.0
- 007
- ta
- 008
- 210728s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/10428194.2020.1861274 $2 doi
- 035 __
- $a (PubMed)33356699
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Folta, Adam $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 245 10
- $a Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients / $c A. Folta, T. Jurcek, B. Kubesova, D. Zackova, L. Semerad, J. Mayer, I. Jeziskova
- 650 _2
- $a bcr-abl fúzní proteiny $x genetika $7 D016044
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chronická myeloidní leukemie $x diagnóza $x genetika $7 D015464
- 650 12
- $a myeloidní leukemie $7 D007951
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jurcek, Tomas $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Kubesova, Blanka $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Zackova, Daniela $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Semerad, Lukas $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Mayer, Jiri $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
- 700 1_
- $a Jeziskova, Ivana $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00003140 $t Leukemia & lymphoma $x 1029-2403 $g Roč. 62, č. 5 (2021), s. 1239-1242
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33356699 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100311 $b ABA008
- 999 __
- $a ok $b bmc $g 1689728 $s 1139160
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 62 $c 5 $d 1239-1242 $e 20201225 $i 1029-2403 $m Leukemia & lymphoma $n Leuk Lymphoma $x MED00003140
- LZP __
- $a Pubmed-20210728